BUZZ-Altimmune falls as CEO Vipin Garg to step down** Shares of drug developer Altimmune ALT.O fall 6.7% to $4.91 premarket
** Co says Chairman Jerry Durso will take over as chief executive officer on January 1, 2026, succeeding Vipin Garg, who has led the company for seven years
** Co says Durso previously led Intercept Pharmaceuticals and spent over 20 years at Sanofi SASY.PA
** Co's lead drug pemvidutide is being developed for liver disease and weight loss - ALT
** ALT expects 48-week mid-stage trial data and FDA meeting on proposed late-stage study before year-end, co says
** Up to last close, stock down ~27% YTD
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments